Literature DB >> 10996834

Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS).

D A Triplett1, R A Asherson.   

Abstract

Antiphospholipid antibodies (APA) are a common cause of acquired thrombophilia. APA recognize plasma phospholipid-binding proteins (e. g., beta(2)-glycoprotein I, prothrombin, annexin V, etc.). Catastrophic antiphospholipid syndrome (CAPS) is an uncommon variant of the antiphospholipid syndrome. CAPS patients often present with multiorgan failure. Precipitating factors include surgical procedures, drugs, and discontinuation of anticoagulant therapy. Increasingly, infections are recognized as a major precipitating condition. The majority of patients present with renal involvement as well as evidence of acute respiratory distress syndrome (ARDS). This review discusses the clinical and pathophysiologic aspects of CAPS as well as the differenital diagnosis. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996834     DOI: 10.1002/1096-8652(200010)65:2<154::aid-ajh11>3.0.co;2-a

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis.

Authors:  Jan Steffen Jürgensen; Ralf Kettritz; Wolfgang Schneider; Herbert Koop; Thorsten Sven Hildebrand; Ulrich Frei; Kai-Uwe Eckardt
Journal:  Rheumatol Int       Date:  2003-03-29       Impact factor: 2.631

2.  Catastrophic antiphospholipid syndrome and pulmonary embolism in a 3-year-old child.

Authors:  Carine Olivier; Eleonore Blondiaux; Thierry Blanc; Jeanne-Yvonne Borg; Jean-Nicolas Dacher
Journal:  Pediatr Radiol       Date:  2006-06-10

3.  Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.

Authors:  Melody Hermel; David Hermel; Saif Azam; Jerold Shinbane; Annahita Sarcon; Erika Jones; Arjun Mehta; Luanda Grazette; Howard Liebman; Ilene Weitz
Journal:  EJHaem       Date:  2020-07-31

Review 4.  Immune response to FVIII in hemophilia A: an overview of risk factors.

Authors:  Kanjaksha Ghosh; Shrimati Shetty
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

5.  The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.

Authors:  W Miesbach; R A Asherson; R Cervera; Y Shoenfeld; J Gomez Puerta; G Espinosa; S Bucciarelli
Journal:  Clin Rheumatol       Date:  2007-05-24       Impact factor: 2.980

6.  Catastrophic antiphospholipid syndrome in a 14-year-old child.

Authors:  George Tsirpanlis; George Moustakas; Eleni Sakka; George Triantafyllis; Flora Sotsiou; Helen Liapis; Panos Ziroyannis
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.651

7.  Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation.

Authors:  W Miesbach; I Scharrer; R A Asherson
Journal:  Clin Rheumatol       Date:  2004-03-20       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.